The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 ...
Wall Street Journal on MSN2d
Amgen Obesity Drug Cut Weight In Closely Watched StudyA highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Biden proposes Medicaid, Medicare cover ...
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback